Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,279

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Humanized mice in translational biomedical research

Shultz, Leonard D., Ishikawa, Fumihiko, Greiner, Dale L.·2007·Nature Reviews Immunology
DOI 10.1038/nri2017
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nri2017

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 137

  1. Bosma, G. C., Custer, R. P. & Bosma, M. J. A severe combined immunodeficiency mutation in the mouse. Nature 301, 527–530 (1983). · DOI · Paper page
  2. Mosier, D. E., Gulizia, R. J., Baird, S. M. & Wilson, D. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335, 256–259 (1988). The original description of the use of CB17- scid mice as hosts for human PBMCs, known as the Hu-PBL-SCID model. · DOI · Paper page
  3. McCune, J. M. et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632–1639 (1988). The original description of the use of CB17- scid mice as hosts for human haematopoietic fetal liver and thymus, resulting in the development of the SCID-hu model. This model is still used, in particular for testing HIV therapeutics. · doi:10.1126/science.2971269 · Paper page
  4. Lapidot, T. et al. Cytokine stimulation of multi-lineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255, 1137–1141 (1992). The original description of the use of CB17- scid mice as hosts for human HSCs and the development of the Hu-SRC-SCID model. · DOI · Paper page
  5. Greiner, D. L., Hesselton, R. A. & Shultz, L. D. SCID mouse models of human stem cell engraftment. Stem Cells 16, 166–177 (1998). · DOI · Paper page
  6. Fulop, G. M. & Phillips, R. A. The scid mutation in mice causes a general defect in DNA repair. Nature 347, 479–482 (1990). · DOI · Paper page
  7. Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869–877 (1992). · DOI · Paper page
  8. Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867 (1992). · DOI · Paper page
  9. Shultz, L. D. et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154, 180–191 (1995). · DOI · Paper page
  10. Hesselton, R. M. et al. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to HIV-1 infection in NOD/LtSz-scid/scid mice. J. Infect. Dis. 172, 974–982 (1995). · DOI · Paper page
  11. Christianson, S. W. et al. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell. Immunol. 171, 186–199 (1996).
  12. Lowry, P. A. et al. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol. Blood Marrow Transplant. 2, 15–23 (1996).
  13. Pflumio, F. et al. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88, 3731–3740 (1996). · DOI · Paper page
  14. Ito, M. et al. NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100, 3175–3182 (2002). This paper describes the development of a human immune system in NOD/Shi- scid Il2rg−/− mice engrafted as adults with human CD34+ cord-blood HSCs. · DOI · Paper page
  15. Traggiai, E. et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304, 104–107 (2004). This paper shows the development of a complete human immune system in BALB/c- Rag2−/−Il2rg−/− mice engrafted intrahepatically as newborns with human cord-blood CD34+ HSCs. · DOI · Paper page
  16. Shultz, L. et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2rgnull mice engrafted with mobilized human hematopoietic stem cells. J. Immunol. 174, 6477–6489 (2005). One of the first studies to show the development of a complete human immune system in NOD- scid Il2rg−/− mice engrafted with human mobilized peripheral-blood CD34+ stem cells. · DOI · Paper page
  17. Ishikawa, F. et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ-chainnull mice. Blood 106, 1565–1573 (2005). The first paper to show that engraftment of newborn NOD/LtSz- scid Il2rg−/− mice with human CD34+ HSCs leads to the generation of a complete haematopoietic system, including red blood cells and platelets. · DOI · Paper page
  18. Sugamura, K. et al. The interleukin-2 receptor γ-chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14, 179–205 (1996). · DOI · Paper page
  19. Cao, X. et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ-chain. Immunity 2, 223–238 (1995). · DOI · Paper page
  20. DiSanto, J. P., Muller, W., Guy-Grand, D., Fischer, A. & Rajewsky, K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ-chain. Proc. Natl Acad. Sci. USA 92, 377–381 (1995). · DOI · Paper page
  21. Ohbo, K. et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ-chain. Blood 87, 956–967 (1996). · DOI · Paper page
  22. Jacobs, H. et al. PIM1 reconstitutes thymus cellularity in interleukin-7- and common γ-chain-mutant mice and permits thymocyte maturation in Rag- but not CD3γ-deficient mice. J. Exp. Med. 190, 1059–1068 (1999). · DOI
  23. Yahata, T. et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101, 2905–2913 (2003). · DOI · Paper page
  24. Gimeno, R. et al. Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn Rag2−/−γ c−/− mice: functional inactivation of p53 in developing T cells. Blood 104, 3886–3893 (2004). · DOI · Paper page
  25. Bryder, D., Rossi, D. J. & Weissman, I. L. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am. J. Pathol. 169, 338–346 (2006). · DOI · Paper page
  26. Zanjani, E. D., Almeida-Porada, G. & Flake, A. W. Retention and multilineage expression of human hematopoietic stem cells in human–sheep chimeras. Stem Cells 13, 101–111 (1995). · doi:10.1002/stem.5530130202
  27. Clutterbuck, R. D. et al. Studies on the development of human acute myeloid leukaemia xenografts in immune-deprived mice: comparison with cells in short-term culture. Leuk. Res. 9, 1511–1518 (1985). · doi:10.1016/0145-2126(85)90044-x
  28. Ganick, D. J., Sarnwick, R. D., Shahidi, N. T. & Manning, D. D. Inability of intravenously injected monocellular suspensions of human bone marrow to establish in the nude mouse. Int. Arch. Allergy Appl. Immunol. 62, 330–333 (1980). · DOI
  29. Shultz, L. D. et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164, 2496–2507 (2000). · DOI · Paper page
  30. Mazurier, F., Doedens, M., Gan, O. I. & Dick, J. E. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nature Med. 9, 959–963 (2003). · DOI · Paper page
  31. Schoeberlein, A. et al. Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice. Stem Cells Dev. 13, 677–684 (2004). · doi:10.1089/scd.2004.13.677
  32. Glimm, H. et al. Previously undetected human hematopoietic cell populations with short- term repopulating activity selectively engraft NOD/SCID-β2 microglobulin-null mice. J. Clin. Invest. 107, 199–206 (2001). · DOI · Paper page
  33. Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M. & Torbett, B. E. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682–686 (1999). · DOI · Paper page
  34. Cohen-Haguenauer, O. et al. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients. Proc. Natl Acad. Sci. USA 103, 2340–2345 (2006). · doi:10.1073/pnas.0510613103
  35. Bleeker, W. K. et al. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy. J. Immunol. 173, 4699–4707 (2004). · DOI
  36. Kolar, G. R., Yokota, T., Rossi, M. I., Nath, S. K. & Capra, J. D. Human fetal, cord blood, and adult lymphocyte progenitors have similar potential for generating B cells with a diverse immunoglobulin repertoire. Blood 104, 2981–2987 (2004). · DOI
  37. Yahata, T. et al. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor-γ-null mice. J. Immunol. 169, 204–209 (2002). · DOI · Paper page
  38. Legrand, N., Weijer, K. & Spits, H. Experimental models to study development and function of the human immune system in vivo. J. Immunol. 176, 2053–2058 (2006). · DOI · Paper page
  39. Matsumura, T. et al. Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/γcnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp. Hematol. 31, 789–797 (2003). · doi:10.1016/s0301-472x(03)00193-0
  40. Legrand, N. et al. Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in 'human immune system' Rag2−/−γ c−/− mice. Blood 108, 238–245 (2006). · DOI · Paper page
  41. Banuelos, S. J. et al. Rejection of human islets and human HLA-A2.1-transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1nullPrf1null mice. Clin. Immunol. 112, 273–283 (2004). · DOI
  42. Camacho, R. E. et al. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice. Cell. Immunol. 232, 86–95 (2004). · doi:10.1016/j.cellimm.2005.02.003
  43. Bajenoff, M. et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25, 989–1001 (2006). · DOI · Paper page
  44. Suematsu, S. & Watanabe, T. Generation of a synthetic lymphoid tissue-like organoid in mice. Nature Biotechnol. 22, 1539–1545 (2004). · DOI · Paper page
  45. Melkus, M. W. et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nature Med. 12, 1316–1322 (2006). · DOI · Paper page
  46. Ifversen, P. & Borrebaeck, C. A. SCID-hu-PBL: a model for making human antibodies? Semin. Immunol. 8, 243–248 (1996). · doi:10.1006/smim.1996.0030
  47. Murphy, W. J., Taub, D. D. & Longo, D. L. The huPBL-SCID mouse as a means to examine human immune function in vivo. Semin. Immunol. 8, 233–241 (1996). · doi:10.1006/smim.1996.0029
  48. Shultz, L. D. et al. NOD/LtSz-Rag1nullPfpnull mice: a new model system to increase levels of human peripheral leukocyte and hematopoietic stem cell engraftment. Transplantation 76, 1036–1042 (2003). · DOI
  49. Christianson, S. W. et al. Enhanced human CD4+ T cell engraftment in β2-microglobulin-deficient NOD-scid mice. J. Immunol. 158, 3578–3586 (1997). · DOI
  50. Tary-Lehmann, M., Lehmann, P. V., Schols, D., Roncarolo, M. G. & Saxon, A. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras. J. Exp. Med. 180, 1817–1827 (1994). · doi:10.1084/jem.180.5.1817
  51. Greiner, D. L. & Shultz, L. D. in NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer and Other Diseases (eds Leiter, E. & Atkinson, M.) 173–203 (Landes Bioscience, Austin, 1998).
  52. May, K. F. Jr et al. Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies. Blood 105, 1114–1120 (2005). · DOI
  53. Murray, A. G. et al. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc. Natl Acad. Sci. USA 91, 9146–9150 (1994). · DOI
  54. Chang, S. K., Arendt, B. K., Darce, J. R., Wu, X. & Jelinek, D. F. A role for BLyS in the activation of innate immune cells. Blood 108, 2687–2694 (2006). · DOI
  55. Woodland, R. T. & Schmidt, M. R. Homeostatic proliferation of B cells. Semin. Immunol. 17, 209–217 (2005). · DOI
  56. Mosier, D. E. et al. EBV-induced human B cell lymphomas in hu-PBL-SCID mice. AIDS Res. Hum. Retroviruses 8, 735–740 (1992). · DOI
  57. Wagar, E. J. et al. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice. J. Immunol. 165, 518–527 (2000). · DOI
  58. van Rijn, R. S. et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in Rag2−/−γ c−/− double-mutant mice. Blood 102, 2522–2531 (2003). · DOI · Paper page
  59. Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17, 211–220 (2002). · DOI · Paper page
  60. Mosier, D. E. Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. Adv. Immunol. 63, 79–125 (1996). · DOI
  61. McCune, J. et al. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu. Rev. Immunol. 9, 399–429 (1991). · doi:10.1146/annurev.iy.09.040191.002151
  62. Davis, P. H. & Stanley, S. L. Jr Breaking the species barrier: use of SCID mouse–human chimeras for the study of human infectious diseases. Cel. Microbiol. 5, 849–860 (2003). · doi:10.1046/j.1462-5822.2003.00321.x
  63. Bente, D. A., Melkus, M. W., Garcia, J. V. & Rico-Hesse, R. Dengue fever in humanized NOD/SCID mice. J. Virol. 79, 13797–13799 (2005). · DOI · Paper page
  64. Islas-Ohlmayer, M. et al. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein–Barr virus. J. Virol. 78, 13891–13900 (2004). · DOI
  65. Kneteman, N. M. et al. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology 43, 1346–1353 (2006). · doi:10.1002/hep.21209
  66. Nelson, F. K., Greiner, D. L., Shultz, L. D. & Rajan, T. V. The immunodeficient scid mouse as a model for human lymphatic filariasis. J. Exp. Med. 173, 659–663 (1991). · DOI
  67. Guirado, E. et al. Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice. Microbes Infect. 8, 1252–1259 (2006). · DOI
  68. Morosan, S. et al. Liver-stage development of Plasmodium falciparum, in a humanized mouse model. J. Infect. Dis. 193, 996–1004 (2006). · doi:10.1086/500840
  69. Moreno, A. et al. The course of infections and pathology in immunomodulated NOD/LtSz-SCID mice inoculated with Plasmodium falciparum laboratory lines and clinical isolates. Int. J. Parasitol. 36, 361–369 (2006). · doi:10.1016/j.ijpara.2005.10.012
  70. Macchiarini, F., Manz, M. G., Palucka, A. K. & Shultz, L. D. Humanized mice: are we there yet? J. Exp. Med. 202, 1307–1311 (2005). · DOI
  71. Lapenta, C. et al. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice. Int. Immunol. 17, 469–475 (2005). · doi:10.1093/intimm/dxh226
  72. Mosier, D. E. Viral pathogenesis in hu-PBL-SCID mice. Semin. Immunol. 8, 255–262 (1996). · doi:10.1006/smim.1996.0032
  73. Ichiyama, K. et al. A duodenally absorbable CXC-chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity. Proc. Natl Acad. Sci. USA 100, 4185–4190 (2003). · DOI
  74. Baenziger, S. et al. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/−γc−/− mice. Proc. Natl Acad. Sci. USA 103, 15951–15956 (2006). · DOI · Paper page
  75. Berges, B. K., Wheat, W. H., Palmer, B. E., Connick, E. & Akkina, R. HIV-1 infection and CD4 T cell depletion in the humanized Rag2−/−γ c−/− (RAG-hu) mouse model. Retrovirology 3, 76 (2006). · DOI · Paper page
  76. Watanabe, S. et al. Hematopoietic stem cell-engrafted NOD/SCID/Il2rγnull mice develop human lymphoid system and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 109, 212–218 (2007). · DOI · Paper page
  77. Petersen, J. S. et al. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Diabetologia 36, 510–515 (1993). · DOI
  78. Martin, A. et al. Characteristics of long-term human thyroid peroxidase autoantibody secretion in scid mice transplanted with lymphocytes from patients with autoimmune thyroiditis. Int. Arch. Allergy Immunol. 98, 317–323 (1992). · DOI
  79. Davis, L. S. et al. Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis. Am. J. Pathol. 160, 357–367 (2002). · doi:10.1016/s0002-9440(10)64379-9
  80. Tighe, H. et al. Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur. J. Immunol. 20, 1843–1848 (1990). · DOI
  81. Gregersen, J. W., Holmes, S. & Fugger, L. Humanized animal models for autoimmune diseases. Tissue Antigens 63, 383–394 (2004). · DOI
  82. Friese, M. A., Jensen, L. T., Willcox, N. & Fugger, L. Humanized mouse models for organ-specific autoimmune diseases. Curr. Opin. Immunol. 18, 704–709 (2006). · DOI
  83. Takaki, T. et al. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J. Immunol. 176, 3257–3265 (2006). · DOI
  84. Wen, L., Chen, N. Y., Tang, J., Sherwin, R. & Wong, F. S. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J. Clin. Invest. 107, 871–880 (2001). · DOI
  85. Marron, M. P., Graser, R. T., Chapman, H. D. & Serreze, D. V. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc. Natl Acad. Sci. USA 99, 13753–13758 (2002). · DOI
  86. Ellmerich, S. et al. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J. Immunol. 174, 1938–1946 (2005). · DOI
  87. Mallone, R. et al. Differential recognition and activation thresholds in human autoreactive GAD-specific T cells. Diabetes 53, 971–977 (2004). · DOI
  88. Holst, J., Vignali, K. M., Burton, A. R. & Vignali, D. A. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nature Methods 3, 191–197 (2006). · DOI
  89. Fogh, J., Fogh, J. M. & Orfeo, T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl Cancer Inst. 59, 221–226 (1977). · DOI · Paper page
  90. Hudson, W. A., Li, Q., Le, C. & Kersey, J. H. Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects. Leukemia 12, 2029–2033 (1998). · DOI
  91. Dick, J. E. & Lapidot, T. Biology of normal and acute myeloid leukemia stem cells. Int. J. Hematol. 82, 389–396 (2005). · DOI
  92. Kawano, N. et al. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/β2-microglobulinnull mice. Leukemia 19, 1384–1390 (2005). · DOI
  93. Nakamura, Y. et al. Engraftment of NOD/SCID/γcnull mice with multilineage neoplastic cells from patients with juvenile myelomonocytic leukaemia. Br. J. Haematol. 130, 51–57 (2005). · DOI
  94. Pardal, R., Clarke, M. F. & Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nature Rev. Cancer 3, 895–902 (2003). · DOI · Paper page
  95. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105–111 (2001). · DOI · Paper page
  96. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730–737 (1997). · DOI · Paper page
  97. Pilarski, L. M. & Belch, A. R. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34+ hematopoietic progenitors. Clin. Cancer Res. 8, 3198–3204 (2002).
  98. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003). · DOI · Paper page
  99. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106–110 (2007). · DOI · Paper page
  100. Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004). · DOI · Paper page
  101. Yoshida, S. et al. Long-term engraftment and self-renewal of AML stem cells in the newborn NOD-scid/Il2rgnull immunodeficient mouse model. Blood 106, A1261 (2005). · DOI
  102. Nomura, T. et al. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice. Cancer Res. 57, 2081–2084 (1997).
  103. Mitsiades, C. S. et al. Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications. Cancer Res. 63, 6689–6696 (2003).
  104. O'Reilly, M. S., Holmgren, L., Chen, C. & Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689–692 (1996). · DOI · Paper page
  105. Siegler, U. et al. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice. Leukemia 19, 2215–2222 (2005). · DOI
  106. Flavell, D. J. et al. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma. Br. J. Haematol. 134, 157–170 (2006). · doi:10.1111/j.1365-2141.2006.06155.x
  107. Trieu, Y. et al. Soluble interleukin-13Rα2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo. Cancer Res. 64, 3271–3275 (2004). · DOI
  108. Dewan, M. Z. et al. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/γcnull mice: suppression by an inhibitor against NF-κB. J. Virol. 77, 5286–5294 (2003). · DOI
  109. Watanabe, M. et al. A novel NF-κB inhibitor DHMEQ selectively targets constitutive NF-κB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo. Int. J. Cancer 114, 32–38 (2005). · DOI
  110. Chalandon, Y. et al. BCR–ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Leukemia 19, 442–448 (2005). · doi:10.1038/sj.leu.2403650
  111. Serakinci, N. & Keith, W. N. Therapeutic potential of adult stem cells. Eur. J. Cancer 42, 1243–1246 (2006). · DOI
  112. Solter, D. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nature Rev. Genet. 7, 319–327 (2006). · DOI · Paper page
  113. Kakinuma, S. et al. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 21, 217–227 (2003). · DOI · Paper page
  114. Tateno, C. et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol. 165, 901–912 (2004). · DOI · Paper page
  115. Ishikawa, F. et al. Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB J. 20, 950–952 (2006). · DOI
  116. Ma, N. et al. Umbilical cord blood cell transplantation for myocardial regeneration. Transplant Proc. 38, 771–773 (2006). · doi:10.1016/j.transproceed.2006.01.061
  117. Torrente, Y. et al. Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 114, 182–195 (2004). · doi:10.1172/jci20325 · Paper page
  118. Ishikawa, F. et al. Human cord blood- and bone marrow-derived CD34+ cells regenerate gastrointestinal epithelial cells. FASEB J. 18, 1958–1960 (2004). · DOI
  119. Droetto, S. et al. Vasculogenic potential of long term repopulating cord blood progenitors. FASEB J. 18, 1273–1275 (2004). · DOI
  120. Taguchi, A. et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330–338 (2004). · DOI · Paper page
  121. Pauwelyn, K. A. & Verfaillie, C. M. Transplantation of undifferentiated, bone marrow-derived stem cells. Curr. Top. Dev. Biol. 74, 201–251 (2006). · DOI
  122. Hess, D. et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nature Biotechnol. 21, 763–770 (2003). · DOI · Paper page
  123. Yoshida, S. et al. Human cord blood-derived cells generate insulin-producing cells in vivo. Stem Cells 23, 1409–1416 (2005). · DOI
  124. Vassilopoulos, G., Wang, P. R. & Russell, D. W. Transplanted bone marrow regenerates liver by cell fusion. Nature 422, 901–904 (2003). · DOI · Paper page
  125. Zhang, S. et al. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34+ cells into cardiomyocytes in vivo. Circulation 110, 3803–3807 (2004). · DOI · Paper page
  126. Stamm, C., Liebold, A., Steinhoff, G. & Strunk, D. Stem cell therapy for ischemic heart disease: beginning or end of the road? Cell Transplant. 15 (Suppl. 1), 47–56 (2006). · doi:10.3727/000000006783982313
  127. Brolen, G. K., Heins, N., Edsbagge, J. & Semb, H. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing β-cell-like cells. Diabetes 54, 2867–2874 (2005). · DOI
  128. Cooke, M. J., Stojkovic, M. & Przyborski, S. A. Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site. Stem Cells Dev. 15, 254–259 (2006). · DOI
  129. Przyborski, S. A. Differentiation of human embryonic stem cells after transplantation in immune-deficient mice. Stem Cells 23, 1242–1250 (2005). · DOI · Paper page
  130. Wang, L. et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J. Exp. Med. 201, 1603–1614 (2005). · DOI · Paper page
  131. Tian, X., Woll, P. S., Morris, J. K., Linehan, J. L. & Kaufman, D. S. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 24, 1370–1380 (2006). · DOI
  132. Galic, Z. et al. T-lineage differentiation from human embryonic stem cells. Proc. Natl Acad. Sci. USA 103, 11742–11747 (2006). · DOI
  133. Robert, J. S. The science and ethics of making part-human animals in stem cell biology. FASEB J. 20, 838–845 (2006). · DOI
  134. Flanagan, S. P. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet. Res. 8, 295–309 (1966). · DOI · Paper page
  135. Mosier, D. E., Stell, K. L., Gulizia, R. J., Torbett, B. E. & Gilmore, G. L. Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation. J. Exp. Med. 177, 191–194 (1993). · DOI
  136. Lapidot, T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann. NY Acad. Sci. 938, 83–95 (2001). · DOI · Paper page
  137. Nicolini, F. E., Cashman, J. D., Hogge, D. E., Humphries, R. K. & Eaves, C. J. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia 18, 341–347 (2004). · DOI

Cited by

See all 1,279

Metadata

Authors
Shultz, L. D., Ishikawa, F., & Greiner, D. L.
Venue
Nature Reviews Immunology
Publisher
Springer Science and Business Media LLC
Published
2007-02
Volume
7
Issue
2
Pages
118-130
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
DOI
10.1038/nri2017
OpenAlex
W2021586066
Cited by
1,279
References
2
FWCI
5.07
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Humanized mice in translational biomedical research. https://app.cochat.ai/papers/10.1038/nri2017
The paper
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007). Humanized mice in translational biomedical research. Nature Reviews Immunology. https://doi.org/10.1038/nri2017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.